State of Wisconsin Investment Board’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,260
Closed -$85K 2911
2022
Q1
$85K Sell
1,260
-520
-29% -$43.3K ﹤0.01% 2217
2021
Q4
$216K Sell
1,780
-1,830
-51% -$309K ﹤0.01% 2079
2021
Q3
$508K Buy
3,610
+1,278
+55% +$253K ﹤0.01% 1689
2021
Q2
$641K Buy
2,332
+1,002
+75% +$253K ﹤0.01% 1607
2021
Q1
$285K Buy
+1,330
New +$368K ﹤0.01% 1914
2020
Q1
Sell
-965
Closed -$78K 1749
2019
Q4
$78K Hold
965
﹤0.01% 1612
2019
Q3
$118K Hold
965
﹤0.01% 1527
2019
Q2
$173K Buy
965
+20
+2% +$3.23K ﹤0.01% 1496
2019
Q1
$151K Buy
+945
New +$187K ﹤0.01% 1483

Other funds holding EVLO

State of Wisconsin Investment Board's EVLO Position: Q2 2022 in Review

State of Wisconsin Investment Board sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2022, closing a stake of 1,260 shares — an estimated $85K sold.

State of Wisconsin Investment Board first reported a position in EVLO in Q1 2019 and held it in 9 quarters. The position peaked at $641K in Q2 2021. 46 funds tracked by Wall St. Rank hold EVLO as of Q2 2022.

  • State of Wisconsin Investment Board reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 1,260 Evelo Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $85K.
  • State of Wisconsin Investment Board first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
  • State of Wisconsin Investment Board's Evelo Biosciences, Inc. Common Stock position peaked at $641K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2022, filed 15 Aug 2022.